hansabiopharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | Hansa |
| Description | Addressing urgent unmet needs in rare Rare Pipeline people Innovation Collaboration Careers Finance Advance treatment Skip to navigation Skip to search This is Hansa This is Hansa Vision, miss |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.174.176.76 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
hansabiopharma.com Valuation
|
US$4,452,872
Last updated: 2023-05-12 03:18:42
hansabiopharma.com has Semrush global rank of 2,376,961. hansabiopharma.com has an estimated worth of US$ 4,452,872, based on its estimated Ads revenue. hansabiopharma.com receives approximately 513,793 unique visitors each day. Its web server is located in United States, with IP address 52.174.176.76. According to SiteAdvisor, hansabiopharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,452,872 |
| Daily Ads Revenue | US$4,111 |
| Monthly Ads Revenue | US$123,311 |
| Yearly Ads Revenue | US$1,479,724 |
| Daily Unique Visitors | 34,253 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| hansabiopharma.com. | A | 3600 | IP: 52.174.176.76 |
| hansabiopharma.com. | NS | 21600 | NS Record: nsgbr.comlaude.co.uk. |
| hansabiopharma.com. | NS | 21600 | NS Record: nssui.comlaude.ch. |
| hansabiopharma.com. | NS | 21600 | NS Record: nsusa.comlaude.net. |
| hansabiopharma.com. | MX | 3600 | MX Record: 0 hansabiopharma-com.mail.protection.outlook.com. |
| hansabiopharma.com. | TXT | 3600 | TXT Record: MS=ms59279294 |
| hansabiopharma.com. | TXT | 3600 | TXT Record: 4k17312kbzd49c63hv86psl7qgvy70cn |
| hansabiopharma.com. | TXT | 3600 | TXT Record: sgs1x5jkbr4mbfpcgh9kl22n0x59brsb |
| hansabiopharma.com. | TXT | 3600 | TXT Record: apple-domain-verification=VotH0o20p8QAXE5o |
| hansabiopharma.com. | TXT | 3600 | TXT Record: adobe-sign-verification=b5f75e7dbe408d7a49877551a1179908 |
| hansabiopharma.com. | TXT | 3600 | TXT Record: onetrust-domain-verification=3fbd967541dd4f3cba94413728ce0fd3 |
| hansabiopharma.com. | TXT | 3600 | TXT Record: v=spf1 ip4:50.31.37.130 ip4:168.245.25.99 ip4:87.253.233.197 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-12 03:18:42
| Rare Pipeline people Innovation Collaboration Careers Finance Advance treatment Skip to navigation Skip to search This is Hansa This is Hansa Vision, mission and strategy Our leadership Corporate governance Governance committees General meeting Remuneration policy Sustainability Our commitment People’s health Environmental impact Partnering History Our therapeutic areas Our therapeutic areas Transplantation Medical advisory board Autoimmune conditions Gene therapy Oncology Our technology platform Our technology platform Imlifidase NiceR Our pipeline and products Our pipeline and products Pipeline Research Investigator sponsored trials Scientific collaborations Products Career Career Why join Hansa Meet our employees Vacancies Investors Investors Press releases Our equity story Presentations Capital Markets Day Financial reports Calendar Stock information Shareholders Annual Report 2022 Analysts and consensus IR contact Media Media Press releases Our stories News and insights |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx/1.18.0 (Ubuntu) Date: Fri, 26 Nov 2021 08:50:28 GMT Content-Type: text/html Content-Length: 178 Connection: keep-alive Location: https://hansabiopharma.com/ HTTP/1.1 301 Moved Permanently Server: nginx/1.18.0 (Ubuntu) Date: Fri, 26 Nov 2021 08:50:28 GMT Content-Type: text/html Content-Length: 178 Connection: keep-alive Location: https://www.hansabiopharma.com/ HTTP/1.1 200 OK Server: nginx Date: Fri, 26 Nov 2021 08:50:29 GMT Content-Type: text/html; charset=utf-8 Content-Length: 31850 Connection: keep-alive Accept-Ranges: bytes Age: 932419 Cache-Control: no-cache Edge-Cache-Tag: hansabiopharma Expect-CT: max-age=0 Expires: Fri, 26 Nov 2021 08:50:28 GMT Last-Modified: Mon, 15 Nov 2021 13:50:11 GMT Referrer-Policy: no-referrer request-context: appId=cid-v1:48f21401-f0f7-4411-a12f-10c37c5b39c9 Strict-Transport-Security: max-age=15552000; includeSubDomains X-Azure-Ref: 0kmWSYQAAAABnK2Enuqu1RLKSPJySPpUeQU1TMDRFREdFMTkyMgBkNTU1NDY4ZC01MmFhLTRjY2EtYjM0OC04MTQ1NTc0YmFlZTQ= X-Cache: HIT X-Content-Type-Options: nosniff X-DNS-Prefetch-Control: off X-Download-Options: noopen X-Permitted-Cross-Domain-Policies: none X-XSS-Protection: 0 Cache-Control: max-age=120 |
hansabiopharma.com Whois Information
Domain Name: HANSABIOPHARMA.COM Registry Domain ID: 2309937497_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2021-08-15T23:05:06Z Creation Date: 2018-09-14T15:54:11Z Registry Expiry Date: 2022-09-14T15:54:11Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NSGBR.COMLAUDE.CO.UK Name Server: NSSUI.COMLAUDE.CH Name Server: NSUSA.COMLAUDE.NET DNSSEC: unsigned >>> Last update of whois database: 2021-11-26T08:17:56Z <<< |